Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean J Barbour

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Nephrology and Renovascular Disease|June 28, 2022
Lipoprotein Glomerulopathy, First Case Report from CanadaJulie Anne Ting, Susanna A McRae, Daniel Schwartz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2026
Cancer Incidence in People With Glomerular Disease: A Population-Level StudyJialin Han, Mark Canney, Yinshan Zhao, et al.
Kidney International|May 23, 2019
Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, CanadaMark Canney, Dilshani Induruwage, Lawrence C McCandless, et al.
The Canadian Journal of Cardiology|September 2, 2019
Glomerular Filtration Rate-Specific Cutoffs Can Refine the Prognostic Value of Circulating Cardiac Biomarkers in Advanced Chronic Kidney DiseaseMark Canney, Mila Tang, Lee Er, et al.
BMC Nephrology|March 22, 2017
Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort studyHolly L Hutton, Adeera Levin, Jagbir Gill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trialMatthew Kadatz, Scott Klarenbach, Helen So, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 29, 2023
Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort StudyMark Canney, Heather M Gunning, James C Johnston, et al.
Canadian Journal of Kidney Health and Disease|October 18, 2021
Podocyte Infolding Glomerulopathy, First Case Report From North AmericaJulie Anne Ting, Wayne Hung, Susanna A McRae, et al.
Canadian Journal of Kidney Health and Disease|July 19, 2016
Recognizing IgG4-related tubulointerstitial nephritisShawna Mann, Michael A Seidman, Sean J Barbour, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Nephrology and Renovascular Disease|June 28, 2022
Lipoprotein Glomerulopathy, First Case Report from CanadaJulie Anne Ting, Susanna A McRae, Daniel Schwartz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 25, 2026
Cancer Incidence in People With Glomerular Disease: A Population-Level StudyJialin Han, Mark Canney, Yinshan Zhao, et al.
Kidney International|May 23, 2019
Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, CanadaMark Canney, Dilshani Induruwage, Lawrence C McCandless, et al.
The Canadian Journal of Cardiology|September 2, 2019
Glomerular Filtration Rate-Specific Cutoffs Can Refine the Prognostic Value of Circulating Cardiac Biomarkers in Advanced Chronic Kidney DiseaseMark Canney, Mila Tang, Lee Er, et al.
BMC Nephrology|March 22, 2017
Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort studyHolly L Hutton, Adeera Levin, Jagbir Gill, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2024
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trialMatthew Kadatz, Scott Klarenbach, Helen So, et al.
Kidney International|August 20, 2015
Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritisSean J Barbour, Daniel C Cattran, Gabriela Espino-Hernandez, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 29, 2023
Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort StudyMark Canney, Heather M Gunning, James C Johnston, et al.
Canadian Journal of Kidney Health and Disease|October 18, 2021
Podocyte Infolding Glomerulopathy, First Case Report From North AmericaJulie Anne Ting, Wayne Hung, Susanna A McRae, et al.
Canadian Journal of Kidney Health and Disease|July 19, 2016
Recognizing IgG4-related tubulointerstitial nephritisShawna Mann, Michael A Seidman, Sean J Barbour, et al.
Pageof 7